SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-15-002329
Filing Date
2015-08-06
Accepted
2015-08-06 17:20:08
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_063015.htm 10-Q 573777
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 10540
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 11205
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5086
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 4890
  Complete submission text file 0001387131-15-002329.txt   2100779

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20150630.xml EX-101.INS 230824
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20150630.xsd EX-101.SCH 22391
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20150630_cal.xml EX-101.CAL 38531
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20150630_def.xml EX-101.DEF 63292
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20150630_lab.xml EX-101.LAB 193780
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20150630_pre.xml EX-101.PRE 142405
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 151034236
SIC: 2834 Pharmaceutical Preparations